| REGENERON PHARMAC.DL-,001 | 517.100 / +0.88% |
| Date/Time | 08/14 / 17:31 |
| Chg. / Chg.(%) | 4.500 / +0.88% |
| Bid | 515.900 / 400 |
| Ask | 519.800 / 400 |
| Open | 517.700 |
| Previous Close | 512.600 |
| High | 520.200 |
| Low | 510.200 |
| Volume [EUR] | 0.000 |
| Volume [Units] | 0 |
| Price fixings | 10 |
| ISIN | US75886F1075 |
| Security | RGO |
| Exchange | Stuttgart |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 514.80 |  |
|
| NASDAQ | 612.5700 | |
302,906 |
| Cboe US | 612.84 | |
14,422 |
| IEX | 612.55 | |
6,497 |
| Mexico | 13,500.21 |  |
426 |
| TradeGate | 516.900 | |
295 |
| Vienna Globa.. | 518.20 | |
94 |
| London Inter.. | 612.45 | |
42 |
| Frankfurt | 515.8000 | |
22 |
| Hamburg | 515.90 | |
5 |
| Düsseldorf | 516.20 | |
0 |
| Berlin | 515.50 | |
0 |
| München | 518.30 | |
0 |
| Stuttgart | 517.100 | |
0 |
| gettex | 517.200 | |
|
| SIX Swiss Ex.. | 304.89 |
News
- Regeneron's net income jumps 365% to $897M in Q2
08/05/2020 / 12:35 - TeleTrader - Regeneron falls over 4% ahead of lower drug prices expectations
07/24/2020 / 17:57 - TeleTrader - Regeneron gets $450M for vaccine advancement
07/07/2020 / 14:40 - TeleTrader - Regeneron to start Phase 3 virus treatment trials
07/06/2020 / 13:35 - TeleTrader - Regeneron starts clinical trial of COVID-19 treatment
06/11/2020 / 13:33 - TeleTrader
Real-time